Cargando…
Fez1/Lzts1 a new mitotic regulator implicated in cancer development
Considerable evidence has accumulated suggesting that cancer has genetic origin, based on the development of genomic alterations, such as deletions, mutations, and/or methylations in critical genes for homeostasis of cellular functions, including cell survival, DNA replication and cell cycle control...
Autores principales: | Vecchione, Andrea, Croce, Carlo M, Baldassarre, Gustavo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075490/ https://www.ncbi.nlm.nih.gov/pubmed/17718912 http://dx.doi.org/10.1186/1747-1028-2-24 |
Ejemplares similares
-
LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer
por: Lovat, Francesca, et al.
Publicado: (2013) -
FEZ2 Has Acquired Additional Protein Interaction Partners Relative to FEZ1: Functional and Evolutionary Implications
por: Alborghetti, Marcos R., et al.
Publicado: (2011) -
FEZ1 Forms Complexes with CRMP1 and DCC to Regulate Axon and Dendrite Development
por: Chua, Jie Yin, et al.
Publicado: (2021) -
LZTS2 and PTEN collaboratively regulate ß-catenin in prostatic tumorigenesis
por: Yu, Eun-Jeong, et al.
Publicado: (2017) -
Novel schizophrenia risk factor pathways regulate FEZ1 to advance oligodendroglia development
por: Chen, Xianjun, et al.
Publicado: (2017)